Frisch Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $743K | Buy |
30,873
+96
| +0.3% | +$2.51K | 0.13% | 89 |
|
|
2026
Q1 | $864K | Sell |
30,777
-5,063
| -14% | -$135K | 0.18% | 68 |
|
|
2025
Q4 | $892K | Sell |
35,840
-5,351
| -13% | -$135K | 0.2% | 67 |
|
|
2025
Q3 | $1.05M | Sell |
41,191
-678
| -2% | -$16.7K | 0.24% | 58 |
|
|
2025
Q2 | $1.01M | Buy |
41,869
+6,051
| +17% | +$141K | 0.25% | 57 |
|
|
2025
Q1 | $908K | Buy |
35,818
+4,705
| +15% | +$123K | 0.25% | 51 |
|
|
2024
Q4 | $825K | Sell |
31,113
-3,221
| -9% | -$87.4K | 0.25% | 51 |
|
|
2024
Q3 | $994K | Buy |
34,334
+1,287
| +4% | +$37.5K | 0.3% | 46 |
|
|
2024
Q2 | $925K | Sell |
33,047
-1,145
| -3% | -$31.5K | 0.28% | 49 |
|
|
2024
Q1 | $949K | Sell |
34,192
-1,903
| -5% | -$52.8K | 0.32% | 42 |
|
|
2023
Q4 | $1.04M | Buy |
36,095
+13,411
| +59% | +$405K | 0.39% | 37 |
|
|
2023
Q3 | $752K | Sell |
22,684
-652
| -3% | -$23.1K | 0.31% | 49 |
|
|
2023
Q2 | $856K | Sell |
23,336
-13,874
| -37% | -$540K | 0.41% | 43 |
|
|
2023
Q1 | $1.52M | Sell |
37,210
-2,632
| -7% | -$114K | 0.59% | 37 |
|
|
2022
Q4 | $2.04M | Buy |
39,842
+4,899
| +14% | +$235K | 0.77% | 35 |
|
|
2022
Q3 | $1.53M | Buy |
34,943
+1,082
| +3% | +$52.6K | 0.65% | 35 |
|
|
2022
Q2 | $1.77M | Buy |
33,861
+1,063
| +3% | +$54.2K | 0.69% | 34 |
|
|
2022
Q1 | $1.7M | Sell |
32,798
-663
| -2% | -$34.4K | 0.55% | 40 |
|
|
2021
Q4 | $1.9M | Sell |
33,461
-682
| -2% | -$33.8K | 0.6% | 40 |
|
|
2021
Q3 | $1.47M | Sell |
34,143
-787
| -2% | -$34.9K | 0.49% | 42 |
|
|
2021
Q2 | $1.37M | Sell |
34,930
-3,763
| -10% | -$146K | 0.43% | 42 |
|
|
2021
Q1 | $1.4M | Buy |
38,693
+2,084
| +6% | +$74K | 0.47% | 41 |
|
|
2020
Q4 | $1.35M | Buy |
36,609
+2,959
| +9% | +$109K | 0.49% | 35 |
|
|
2020
Q3 | $1.17M | Sell |
33,650
-46
| -0.1% | -$1.61K | 0.51% | 33 |
|
|
2020
Q2 | $1.05M | Sell |
33,696
-5,315
| -14% | -$181K | 0.49% | 31 |
|
|
2020
Q1 | $1.21M | Sell |
39,011
-19
| -0% | -$647 | 0.7% | 28 |
|
|
2019
Q4 | $1.45M | Buy |
39,030
+7,113
| +22% | +$253K | 0.69% | 29 |
|
|
2019
Q3 | $1.09M | Buy |
31,917
+4,120
| +15% | +$150K | 0.66% | 29 |
|
|
2019
Q2 | $1.14M | Sell |
27,797
-2,336
| -8% | -$92.8K | 0.76% | 24 |
|
|
2019
Q1 | $1.21M | Buy |
30,133
+726
| +2% | +$29.1K | 0.74% | 27 |
|
|
2018
Q4 | $1.22M | Buy |
+29,407
| New | +$1.22M | 0.85% | 27 |
|
Other funds holding PFE
Frisch Financial Group's PFE Position: Q2 2026 in Review
Frisch Financial Group increased its Pfizer (PFE) stake by 0.31% in Q2 2026, buying an estimated $2.51K and bringing the position to 30,873 shares worth $743K. The position accounts for 0.13% of the portfolio, ranked #89.
Frisch Financial Group first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.04M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Frisch Financial Group held 30,873 shares of Pfizer worth $743K as of Q2 2026.
- Frisch Financial Group bought 96 Pfizer shares in Q2 2026, an estimated $2.51K.
- Pfizer made up 0.13% of Frisch Financial Group's portfolio in Q2 2026, its #89 holding.
- Frisch Financial Group first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Frisch Financial Group's Pfizer position peaked at $2.04M in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Frisch Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.